Given that the rates of BC incidence and mortality in Argentina are among the highest in the world [23, 24], a better understanding of the impact of BRCA1/BRCA2-related disease in Argentinean BOC patients is important for the implementation of prevention and/or early detection strategies. The gene discussed is BRCA1; the disease is breast cancer.